SCHEMBL3511142

SCHEMBL3511142

CCn1c2ccccc2c2cccc(N)c21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.56
HTT P42858 5/20 0.56
MAPT P10636 5/20 0.56
ALDH1A1 P00352 4/20 0.56
MAPK1 P28482 3/20 0.56
HSD17B10 Q99714 3/20 0.56
MEN1 O00255 3/20 0.56
KMT2A Q03164 3/20 0.56
HPGD P15428 2/20 0.56
TDP1 Q9NUW8 2/20 0.56
HBB P68871 1/20 0.56
CYP1A2 P05177 2/20 0.45
CYP2C19 P33261 1/20 0.45
PGR P06401 1/20 0.45
LMNA P02545 4/20 0.44
NSD2 O96028 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
POLB P06746 2/20 0.43
NPY5R Q15761 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30412874 1.00 KDM4E (0.56) KDM4EHTTMAPTALDH1A1MAPK1
SCHEMBL14208786 0.83 ALDH1A1 (0.59) KDM4EHTTMAPTALDH1A1MAPK1
SCHEMBL23966412 0.82 CYP1A2 (0.45) KDM4EHTTMAPTALDH1A1MAPK1
SCHEMBL17885720 0.81 ALDH1A1 (0.53) KDM4EHTTMAPTALDH1A1MAPK1
Hydrazine SCHEMBL28023249 0.81 KDM4E (0.51) KDM4EHTTMAPTALDH1A1MAPK1
SCHEMBL8178240 0.80 ALKBH5 (0.59) KDM4EHTTMAPTALDH1A1MAPK1
SCHEMBL11234358 0.80 NPY5R (0.46) KDM4EHTTMAPTALDH1A1MAPK1
SCHEMBL29139893 0.79 ALDH1A1 (0.50) KDM4EHTTMAPTALDH1A1MAPK1
SCHEMBL14243728 0.79 KDM4E (0.56) KDM4EHTTMAPTALDH1A1MAPK1
SCHEMBL16865773 0.79 ALDH1A1 (0.50) KDM4EHTTMAPTALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023075517-A1 PRUSSIAN BLUE NANOPARTICLE-BASED OPTICAL AND ELECTROCHEMICAL BIOSENSOR 한국기초과학지원연구원 2023-05-04 WO claimed
CN-110741302-B Process recording slide for immunohistochemical staining 深圳市诺高实验器材有限公司 2021-11-16 CN claimed
CN-110741302-A Process recording slide for immunohistochemical staining 日光石科技有限公司 2020-01-31 CN claimed
EP-1102763-A2 FSH MIMETICS FOR THE TREATMENT OF INFERTILITY Applied Research Systems ARS Holding N.V. (AN) 2001-05-30 EP claimed
WO-2000008015-A2 FSH MIMETICS FOR THE TREATMENT OF INFERTILITY APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2000-02-17 WO claimed
US-4687736-A Detection of biological substances by specific labelling techniques THE UNIVERSITY OF WALES COLLEGE OF MEDICINE (GB) 1987-08-18 US claimed
EP-4306612-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE Samsung Electronics Co., Ltd. (KR) 2024-01-17 EP disclosed
US-11653560-B2 Tetradentate metal complexes with carbon group bridging ligands ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2023-05-16 US disclosed
US-20220233428-A1 HAIR TREATMENT METHOD KAO CORPORATION (JP) 2022-07-28 US disclosed
EP-4016656-A1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND Samsung Electronics Co., Ltd. (KR) 2022-06-22 EP disclosed
EP-3992199-A1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE Samsung Electronics Co., Ltd. (KR) 2022-05-04 EP disclosed
EP-3992200-A1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANOMETALLIC COMPOUND, AND DIAGNOSTIC COMPOSITION INCLUDING ORGANOMETALLIC COMPOUND Samsung Electronics Co., Ltd. (KR) 2022-05-04 EP disclosed
EP-3971260-A1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE Samsung Electronics Co., Ltd. (KR) 2022-03-23 EP disclosed
WO-1993022349-A1 NATURAL HUMAN IgM ANTIBODIES THE INSTITUTE FOR HUMAN GENETICS AND BIOCHEMISTRY (CH) 1993-11-11 WO disclosed
US-5198356-A Expression of growth factors CHILDREN'S HOSPITAL MEDICAL CENTER (US) 1993-03-30 US disclosed
US-5147798-A Monophenotypic xenograft of megakaryocytic lineage and origin CHILDREN'S HOSPITAL MEDICAL CENTER (US) 1992-09-15 US disclosed
EP-0097666-A1 METHOD FOR DOSING BIOLOGICAL SUBSTANCES CAPABLE OF FIXING DEGRADATION PRODUCTS OF ADENOSINE 5'-TRIPHOSPHORIC ACID. PASTEUR INSTITUT (FR) 1984-01-11 EP disclosed
WO-1983002276-A1 MODIFIED ADENOSINE 5'-TRIPHOSPHORIC ACID AND METHOD FOR DOSING BIOLOGICAL SUBSTANCES CAPABLE OF FIXING DEGRADATION PRODUCTS OF ADENOSINE 5'-TRIPHOSPHORIC ACID KOURILSKY, PHILIPPE 1983-07-07 WO disclosed
EP-0014678-A1 Basic dioxazine compounds, process for their preparation and their use in dyeing and printing textile materials, paper and leather, and materials dyed and printed therewith CIBA-GEIGY AG (CH) 1980-08-20 EP disclosed
US-3947463-A Certain 2-amino-nicotinonitrile derivatives CASSELLA FARBWERKE MAINKUR AG (DT) 1976-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220233428-A1 HAIR TREATMENT METHOD OXER1, TET3, OXGR1 KDM4E 840/4885HTT 3700/4885MAPT 3086/4885
US-11653560-B2 Tetradentate metal complexes with carbon group bridging ligands PDCD2L, STAU1, POLR1G KDM4E 4207/4885HTT 3745/4885MAPT 258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.